© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2
aDepartment of Laboratory Medicine, Yamanashi Medical University, Nakakoma, Yamanashi 409-3898, Japan
bDepartment of Gastroenterology, University of Tokyo School of Medicine, Tokyo, Japan
* Corresponding author. Tel.: +81-55-273-9694; fax: +81-55-273-6924. yatomiy{at}res.yamanashi-med.ac.jp
Objectives: Sphingosine 1-phosphate (Sph-1-P), a bioactive lipid derived from activated platelets, may play an important role in coronary artery spasm and hence the pathogenesis of ischemic heart diseases, since we reported that a decrease in coronary blood flow was induced by this lysophospholipid in an in vivo canine heart model [Cardiovasc. Res. 46 (2000) 119]. In this study, metabolism related to and cellular responses elicited by Sph-1-P were examined in human coronary artery smooth muscle cells (CASMCs). Methods and results: [3H]Sphingosine (Sph), incorporated into CASMCs, was converted to [3H]Sph-1-P intracellularly, but its stimulation-dependent formation and extracellular release were not observed. Furthermore, the cell surface Sph-1-P receptors of S1P family (previously called EDG) were found to be expressed in CASMCs. Accordingly, Sph-1-P seems to act as an extracellular mediator in CASMCs. Consistent with Sph-1-P-elicited coronary vasoconstriction in vivo, Sph-1-P strongly induced CASMC contraction, which was inhibited by JTE-013, a newly-developed specific antagonist of S1P2 (EDG-5). Furthermore, C3 exoenzyme or Y-27632 inhibited the CASMC contraction induced by Sph-1-P, indicating Rho involvement. Finally, exogenously-added [3H]Sph-1-P underwent a rapid degradation. Since lipid phosphate phosphatases, ectoenzymes capable of dephosphorylating Sph-1-P, were expressed in CASMCs, Sph-1-P may be dephosphorylated by the ectophosphatases. Conclusions: Sph-1-P, derived from platelets and dephosphorylated on the cell surface, may induce the contraction of coronary artery smooth muscle cells through the S1P2/Rho signaling.
KEYWORDS Lipid metabolism; Receptor; Signal transduction; Smooth muscle; Vasoconstriction/dilation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Igarashi and T. Michel Sphingosine-1-phosphate and modulation of vascular tone Cardiovasc Res, May 1, 2009; 82(2): 212 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Skoura and T. Hla Regulation of vascular physiology and pathology by the S1P2 receptor subtype Cardiovasc Res, May 1, 2009; 82(2): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ikeda, N. Watanabe, I. Ishii, T. Shimosawa, Y. Kume, T. Tomiya, Y. Inoue, T. Nishikawa, N. Ohtomo, Y. Tanoue, et al. Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2 J. Lipid Res., March 1, 2009; 50(3): 556 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Lee, S. Gordon, R. Estrada, L. Wang, D. L. Siow, B. W. Wattenberg, D. Lominadze, and M.-J. Lee Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H33 - H42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kimura, T. Ohmori, Y. Kashiwakura, R. Ohkawa, S. Madoiwa, J. Mimuro, K. Shimazaki, Y. Hoshino, Y. Yatomi, and Y. Sakata Antagonism of Sphingosine 1-Phosphate Receptor-2 Enhances Migration of Neural Progenitor Cells Toward an Area of Brain Infarction * Supplemental Materials and Methods Stroke, December 1, 2008; 39(12): 3411 - 3417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hashimoto, X. Wang, L. Mao, T. Kobayashi, S. Kawasaki, N. Mori, M. L. Toews, H. J. Kim, D. R. Cerutis, X. Liu, et al. Sphingosine 1-Phosphate Potentiates Human Lung Fibroblast Chemotaxis through the S1P2 Receptor Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 356 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takabe, S. W. Paugh, S. Milstien, and S. Spiegel "Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets Pharmacol. Rev., June 1, 2008; 60(2): 181 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Argraves and W. S. Argraves HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects J. Lipid Res., November 1, 2007; 48(11): 2325 - 2333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Osada, Y. Yatomi, T. Ohmori, S. Aoki, S. Hosogaya, and Y. Ozaki Involvement of Sphingosine 1-Phosphate, a Platelet-Derived Bioactive Lipid, in Contraction of Mesangium Cells J. Biochem., September 1, 2007; 142(3): 351 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Leiber, Y. Banno, and Z. Tanfin Exogenous sphingosine 1-phosphate and sphingosine kinase activated by endothelin-1 induced myometrial contraction through differential mechanisms Am J Physiol Cell Physiol, January 1, 2007; 292(1): C240 - C250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Lorenz, L. J. Arend, R. Robitz, R. J. Paul, and A. J. MacLennan Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R440 - R446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Hu, S. Mahavadi, J. Huang, F. Li, and K. S. Murthy Characterization of S1P1 and S1P2 receptor function in smooth muscle by receptor silencing and receptor protection Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G605 - G610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schubert Non-capacitative calcium entry-Extension of the possibilities for calcium entry in vascular tissue Cardiovasc Res, October 1, 2005; 68(1): 5 - 7. [Full Text] [PDF]
|
|
|
|
|
|
S. Aoki, Y. Yatomi, M. Ohta, M. Osada, F. Kazama, K. Satoh, K. Nakahara, and Y. Ozaki Sphingosine 1-Phosphate-Related Metabolism in the Blood Vessel J. Biochem., July 1, 2005; 138(1): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tolle, B. Levkau, P. Keul, V. Brinkmann, G. Giebing, G. Schonfelder, M. Schafers, K. v. W. Lipinski, J. Jankowski, V. Jankowski, et al. Immunomodulator FTY720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S1P3 Circ. Res., April 29, 2005; 96(8): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Damirin, H. Tomura, M. Komachi, M. Tobo, K. Sato, C. Mogi, H. Nochi, K. Tamoto, and F. Okajima Sphingosine 1-Phosphate Receptors Mediate the Lipid-Induced cAMP Accumulation through Cyclooxygenase-2/Prostaglandin I2 Pathway in Human Coronary Artery Smooth Muscle Cells Mol. Pharmacol., April 1, 2005; 67(4): 1177 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lockman, J. S. Hinson, M. D. Medlin, D. Morris, J. M. Taylor, and C. P. Mack Sphingosine 1-Phosphate Stimulates Smooth Muscle Cell Differentiation and Proliferation by Activating Separate Serum Response Factor Co-factors J. Biol. Chem., October 8, 2004; 279(41): 42422 - 42430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Forrest, S.-Y. Sun, R. Hajdu, J. Bergstrom, D. Card, G. Doherty, J. Hale, C. Keohane, C. Meyers, J. Milligan, et al. Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 758 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhou and K. S. Murthy Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2 Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1130 - C1138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Saba and T. Hla Point-Counterpoint of Sphingosine 1-Phosphate Metabolism Circ. Res., April 2, 2004; 94(6): 724 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Sanna, J. Liao, E. Jo, C. Alfonso, M.-Y. Ahn, M. S. Peterson, B. Webb, S. Lefebvre, J. Chun, N. Gray, et al. Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate J. Biol. Chem., April 2, 2004; 279(14): 13839 - 13848. [Abstract] [Full Text] [PDF]
|
|